Information on the molecular mechanisms involved in cell growth control is important for understanding the events surrounding normal development and those underlying carcinogenesis. The epidermal growth factor (EGF) is a ligand-stimulated protein-tyrosine kinase that undergoes rapid EGF-induced self-phosphorylation in its extreme carboxy- (C-) terminus. The EGF receptor is homologous to the retroviral transforming protein v-erbB, and it is overexpressed in certain human tumors. Of interest are two general mutations in erbB that increase its oncogenic capacity: an amino-terminal deletion that removes the EGF binding site, and various C-terminal truncations. In this regard, our initial studies have suggested that removal of the C-terminal self-phosphorylation domain decreases high affinity binding, increases tyrosine kinase activity in vivo and disrupts receptor association with the cell cytoskeleton. Moreover, these and other investigations strongly suggest that the receptor C-terminal domain and receptor interaction with the cell cytoskeleton can both exert control over EGF receptor binding and kinase activities. Because EGF receptor kinase activity is essential for proper biological function, the following specific aims are proposed: 1) Examine the mechanisms by which the EGF receptor C-terminus regulates protein-tyrosine kinase activity. These studies will involve an analysis of the substrate specificity, kinetic mechanism and sensitivity to protein activators of both normal and C- terminally mutated EGF receptors. 2) Characterize the role of the EGF receptor C-terminus in promoting cytoskeletal attachment, and ascertain the processes by which cytoskeletal association affects receptor high affinity binding and protein-tyrosine kinase activity. This work will focus on the influence of C-terminal domains and protein kinase C activation on receptor cytoskeletal distribution, and will also asses the effects of cytoskeletal association on receptor high affinity binding, tyrosine kinase activity and substrate specificity. 3) Identify and analyze specific proteins involved in the EGF receptor-cytoskeletal association using direct binding studies, as well as co-immunoprecipitation and crosslinking analyses. These experiences are expected to more rigorously establish the mechanisms by which specific domains, and their interaction with the cellular cytoskeleton, can play a key role in the regulation of EGF receptor function in both normal and abnormal cell growth.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA047881-05
Application #
3191709
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1988-08-01
Project End
1994-07-31
Budget Start
1992-08-01
Budget End
1993-07-31
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Watters, Jyoti J; Sommer, Julie A; Pfeiffer, Zachary A et al. (2002) A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: the MEK/ERK pathway is not essential for nitric oxide and interleukin 1beta production. J Biol Chem 277:9077-87
Denlinger, L C; Garis, K A; Sommer, J A et al. (1998) Nuclear translocation of NF-kappaB in lipopolysaccharide-treated macrophages fails to correspond to endotoxicity: evidence suggesting a requirement for a gamma interferon-like signal. Infect Immun 66:1638-47
Wiepz, G J; Houtman, J C; Cha, D et al. (1997) Growth hormone attenuation of epidermal growth factor-induced mitogenesis. J Cell Physiol 173:44-53
Denlinger, L C; Fisette, P L; Garis, K A et al. (1996) Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem 271:337-42
Lin, M L; Bertics, P J (1995) Laminin responsiveness is associated with changes in fibroblast morphology, motility, and anchorage-independent growth: cell system for examining the interaction between laminin and EGF signaling pathways. J Cell Physiol 164:593-604
Proctor, R A; Denlinger, L C; Leventhal, P S et al. (1994) Protection of mice from endotoxic death by 2-methylthio-ATP. Proc Natl Acad Sci U S A 91:6017-20
Duello, T M; Bertics, P J; Fulgham, D L et al. (1994) Localization of epidermal growth factor receptors in first- and third-trimester human placentas. J Histochem Cytochem 42:907-15
Gronowski, A M; Bertics, P J (1993) Evidence for the potentiation of epidermal growth factor receptor tyrosine kinase activity by association with the detergent-insoluble cellular cytoskeleton: analysis of intact and carboxy-terminally truncated receptors. Endocrinology 133:2838-46
Bates, M E; Bertics, P J; Calhoun, W J et al. (1993) Increased protein kinase C activity in low density eosinophils. J Immunol 150:4486-93
Leventhal, P S; Bertics, P J (1993) Activation of protein kinase C by selective binding of arginine-rich polypeptides. J Biol Chem 268:13906-13

Showing the most recent 10 out of 15 publications